|
|
|
|
Middlebrook expands physician access to Moxatag samples
WESTLAKE, Texas MiddleBrook Pharmaceuticals Inc.is expanding its IncreaseRx promotion program for Moxatag amoxicillin extended-release tablets. The company said Wednesday that under an agreement with DoctorDirectory.com Inc., its promotional partner...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx Promotion for MOXATAG
WESTLAKE, Texas - (Business Wire) MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Companys promotion partner for MOXATAG (amoxicillin extended-release) Tablets,...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx Promotion for MOXATAG
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Companys promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx Promotion for MOXATAG
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
(BUSINESS WIRE) ----MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
(BUSINESS WIRE) ----MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
(BUSINESS WIRE) ----MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to...
|
|
|
MiddleBrook Pharmaceuticals, DoctorDirectory.com enter into agreement to expand IncreaseRx promotion program
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Companys promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
Dave Becker, acting president and chief executive officer of MiddleBrook said, "Under this expanded IncreaseRx(R) program, physicians who previously received MOXATAG samples and information from MiddleBrook field sales representatives will be able to...
|
|
|
MiddleBrook Pharma (MBRK) Enters Agreement to Expand Previously Announced IncreaseRx(R) Promotion Program
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; E
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value. Reduction in...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; E
WESTLAKE, Texas-- (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to...
|
|
|
MiddleBrook Pharmaceuticals reports revenue of $2.6M for fourth-quarter of 2009
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value. On behalf of...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint Gleacher to Assist in
WESTLAKE, Texas--(BUSINESS WIRE)--MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; E
- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value. Reduction...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; E
WESTLAKE, Texas--(BUSINESS WIRE)-- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint Gleacher to Assist in the Evaluation of Strategic Options
WESTLAKE, Texas--(BUSINESS WIRE)--MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK - News) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and
MiddleBrook Pharmaceuticals, Inc.MBRK today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value. Reduction in Force:...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint Gleacher to Assist in the Evaluation of Strategic Options
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value. Reduction in...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces
BusinessWire - MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to maximize shareholder value....
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-...
Company: MiddleBrook Pharmaceuticals Inc (MBRK) MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint
(BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK | Quote | Chart | News | PowerRating) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic...
|
|
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint Gleacher to Assist in the Evaluation of Strategic Options
WESTLAKE, Texas--(BUSINESS WIRE)-- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic alternatives to...
|
|
|
MiddleBrook Pharmaceuticals Announces Promotion Partnership with DoctorDirectory.com for MOXATAG (extended-release amoxicillin) Tablets, 775mg
_ MiddleBrook Pharmaceuticals Announces Promotion Partnership with DoctorDirectory.com for MOXATAG (extended-release amoxicillin) Tablets, 775mg.
|
